Gliclazida Basi

Gliclazide is an oral medication used to manage blood sugar levels in adults with type 2 diabetes. This antidiabetic agent helps improve insulin sensitivity and glucose control.

Gliclazide is primarily used to treat type 2 diabetes by lowering blood sugar levels. It works by stimulating the pancreas to produce more insulin and improving the body's response to insulin. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise. Gliclazide is not suitable for treating type 1 diabetes or diabetic ketoacidosis.

Common effects of Gliclazide may include hypoglycemia, nausea, and digestive discomfort. Some users may experience dizziness or headaches. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Gliclazide should be handled with care, especially by individuals with a history of liver or kidney disease. It is important to monitor blood sugar levels regularly while using this medication. Patients should also be cautious when engaging in activities that require alertness, as Gliclazide can cause dizziness.

Gliclazide may interact with other medications, including certain antibiotics, antifungal drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be avoided as it can increase the risk of hypoglycemia. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.